Nanoencapsulation and characterization of Albizia chinensis isolated antioxidant quercitrin on PLA nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 82, Issue 1, 2011, Pages 224-232

  Kumari, Avnesh ^a   Yadav, Sudesh Kumar ^a   Pakade, Yogesh B ^a   Kumar, Vineet ^a   Singh, Bikram ^a   Chaudhary, Abha ^a   Yadav, Subhash Chandra ^a  

^a CSIR INSTITUTE OF HIMALAYAN BIORESOURCE TECHNOLOGY   (India)

Author keywords

Antioxidant; DPPH; In vitro release; PLA; Quenching; Quercitrin

Indexed keywords

ANTIOXIDANT; DPPH; IN-VITRO; PLA; QUERCITRIN;

ENCAPSULATION; MEDICAL NANOTECHNOLOGY; QUENCHING;

NANOPARTICLES;

1,1 DIPHENYL 2 PICRYLHYDRAZYL; NANOPARTICLE; POLYLACTIDE; QUERCITRIN;

ALBIZIA CHINENSIS; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG ISOLATION; DRUG RELEASE; DRUG SOLUBILITY; EVAPORATION; EVERGREEN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOLECULAR STABILITY; NANOANALYSIS; NANOENCAPSULATION; PARTICLE SIZE; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL;

ALBIZZIA; ANIMALS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FREE RADICAL SCAVENGERS; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; NANOTECHNOLOGY; PICRATES; POLYESTERS; QUERCETIN; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

ALBIZIA CHINENSIS;

EID: 77957666177     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.08.046     Document Type: Article

References (62)

1. Ader P., Wessmann A., Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic. Biol. Med. 2000, 28(7):1056-1067.
2. Banakar U.V. Polymeric Nanoparticles and Microspheres 1986, CRC Press Inc., Boca Raton.
3. Bisht S., Soni S., Ravi R., Kaikar C., Maitra A., Maitra A. Polymeric nanoparticle-encapsulated curcumin (nanocurcumin): a novel strategy for cancer therapy. J. Nanobiotechnol. 2007, 5:3.
4. Budhian A., Siegel S.J., Winey K.I. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol. J. Microencapsul. 2005, 22(7):773-785.
5. Campos A.M.D., Saónchez A., Alonso M.J. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm. 2001, 224:159-168.
6. Camuesco D., Comalada M., Rodriguez-Cabezas M.E., Nieto A., Lorente M.D., Concha A., Zarzuelo A., Galvez J. The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br. J. Pharmacol. 2004, 143(7):908-918.
7. Damge C., Maincent P., Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J. Control. Release 2007, 117(2):163-170.
8. Davis R.A., Simpson M.M., Nugent R.B., Carroll A.R., Avery V.M., Rali T., Chen H., Qurallo B., Quinn R.J. Pim2 inhibitors from the Papua New Guinean plant Cupaniopsis macropetala. J. Nat. Prod. 2008, 71(3):451-452.
9. Desco M.C., Asensi M., Marquez R., Martinez-Valls J., Vento M., Pallardo F.V., Sastre J., Vina J. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002, 51(4):1118-1124.
10. Duchene D., Ponchel G. Principle and investigation of the bioadhesion mechanism of solid dosage forms. Biomaterials 1992, 13(10):709-714.
11. Fassas A., Buffels R., Kaloyannidis P., Anagnostopoulos A. Safety of high-dose liposomal daunorubicin (daunoxome) for refractory or relapsed acute myeloblastic leukaemia. Br. J. Haematol. 2003, 122(1):161-163.
12. Fishbein I., Chorny M., Rabinovich L., Banai S., Gati I., Golomb G. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis. J. Control. Release 2000, 65(1-2):221-229.
13. Galindo-Rodriguez S., Allemann E., Fessi H., Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm. Res. 2004, 21(8):1428-1439.
14. Gao H., Wang Y.N., Fan Y.G., Ma J.B. Synthesis of a biodegradable tadpole-shaped polymer via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-beta-cyclodextrin and its properties as the new carrier of protein delivery system. J. Control. Release 2005, 107(1):158-173.
15. Gong C., Wei X., Wang X., Wang Y., Guo G., Mao Y., Luo F., Qian Z. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery. I. Preparation and characterization. Nanotechnology 2010, 21(21):215103.
16. Gou M., Zheng X., Men K., Zhang J., Zheng L., Wang X., Luo F., Zhao Y., Zhao X., Wei Y., Qian Z. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery. J. Phys. Chem. B 2009, 113(39):12928-12933.
17. Gurny R., Peppas N.A., Harrington D.D., Banker G.S. Development of biodegradable and injectable latices for controlled release of potent drugs. Drug. Dev. Ind. Pharm. 1981, 7:1.
18. Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 2002, 13(10):572-584.
19. Leroux J.-C., Allémann E., De Jaeghere F., Doelker E., Gurny R. Biodegradable nanoparticles-from sustained release formulations to improved site specific drug delivery. J. Control. Release 1996, 39:339-350.
20. Jung M., Park M. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules 2007, 12(9):2130-2139.
21. Kaneria M.S., Naik S.R., Kohli R.K. Anti-inflammatory, antiarthritic and analgesic activity of a herbal formulation (DRF/AY/4012). Indian J. Exp. Biol. 2007, 45(3):278-284.
22. Kreutera J., Petrov V.E., Kharkevich D.A., Alyautdin A.N. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles. J. Control. Release 1997, 49:81-87.
23. Kumar N., Bhandari P., Singh B., Bari S.S. Antioxidant activity and ultra-performance LC-electrospray ionization-quadrupole time-of-flight mass spectrometry for phenolics-based fingerprinting of Rose species: Rosa damascena, Rosa bourboniana and Rosa brunonii. Food Chem. Toxicol. 2009, 47(2):361-367.
24. Kumari A., Yadav S.K., Pakade Y.B., Singh B., Yadav S.C. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf. B: Biointerfaces 2010, 80(2):184-192.
25. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. J. Colloids Surf. B: Biointerfaces 2010, 75:1-18.
26. Lamprecht A., Schafer U., Lehr C.M. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 2001, 18(6):788-793.
27. Lee S.H., Zhang Z., Feng S.S. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. Biomaterials 2007, 28(11):2041-2050.
28. Lemos-Sennaa E., Wouessidjeweb D., Lesieura S., Duchênea D. Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading. Int. J. Pharm. 1998, 170:119.
29. Materska M., Perucka I. Antioxidant activity of the main phenolic compounds isolated from hot pepper fruit (Capsicum annuum L.). J. Agric. Food Chem. 2005, 53(5):1750-1756.
30. Matsumoto J., Nakada Y., Sakurai K., Nakamura T., Takahashi Y. Preparation of nanoparticles consisted of poly(l-lactide)-poly(ethylene glycol)-poly(l-lactide) and their evaluation in vitro. Int. J. Pharm. 1999, 185(1):93-101.
31. Melia C.D., Rajabi-Siahboomi A.R., Hodsdon A.C., Adler J., Mitchell J.R. Structure and behaviour of hydrophilic matrix sustained release dosage forms. 1. The origin and mechanism of formation of gas bubbles in the hydrated surface layer. Int. J. Pharm. 1993, 100:263-269.
32. Mimić-Oka J., Simić D.V., Simić T.P. Free radicals in cardiovascular diseases. Facta Univ. Series: Med. Biol. 1999, 6(1):11-22.
33. Mulholland P.J., Ferry D.R., Anderson D., Hussain S.A., Young A.M., Cook J.E., Hodgkin E., Seymour L.W., Kerr D.J. Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann. Oncol. 2001, 12(2):245-248.
34. Namazi M. Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link. J. Autoimmune Dis. 2009, 6(4):1-5.
35. Peluso M.R. Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp. Biol. Med. (Maywood) 2006, 231(8):1287-1299.
36. Plard J.-P., Bazile D. Comparison of the safety profiles of PLA50 and Me.PEG-PLA50 nanoparticles after single dose intravenous administration to rat. Colloids Surf. B 1999, 16:173-183.
37. Pralhad T., Rajendrakumar K. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J. Pharm. Biomed. Anal. 2004, 34(2):333-339.
38. Raghuvanshi R.S., Katare Y.K., Lalwani K., Ali M.M., Singh O., Panda A.K. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. Int. J. Pharm. 2002, 245(1-2):109-121.
39. Ratnam D.V., Ankola D.D., Bhardwaj V., Sahana D.K., Kumar M.N. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J. Control. Release 2006, 113(3):189-207.
40. Riihimaki L.H., Vainio M.J., Heikura J.M.S., Valkonen K.H., Virtanen V.T., Vuorela P.M. Binding of phenolic compounds and their derivatives to Bovine and Reindeer b-lactoglobulin. J. Agric. Food Chem. 2008, 56(17):7721-7729.
41. 2. Ann. Oncol. 2000, 11(8):1029-1033.
42. Sahoo S.K., Panyam J., Prabha S., Labhasetwar V. Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release 2002, 82(1):105-114.
43. Salim A.S. Role of free radicals in gastrointestinal cancer. Singapore Med. J. 1996, 37(3):295-298.
44. Schroeder U., Sommerfeld P., Ulrich S., Sabel B.A. Nanoparticle technology for delivery of drugs across the blood-brain barrier. J. Pharm. Sci. 1998, 87(11):1305-1307.
45. Sendo T., Teshima D., Makino K., Mishima K., Itoh Y., Oishi R. Application of dynamic laser scattering to the quality control of injectable drugs: polymer formation in ampicillin solution. J. Clin. Pharm. Ther. 2002, 27(2):79-84.
46. Shah K.A., Joshi M.D., Patravale V.B. Biocompatible microemulsions for fabrication of glyceryl monostearate solid lipid nanoparticles (SLN) of tretinoin. J. Biomed. Nanotechnol. 2009, 5(4):396-400.
47. Shakweh M., Besnard M., Nicolas V., Fattal E. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice. Eur. J. Pharm. Biopharm. 2005, 61(1-2):1-13.
48. Shenoy D.B., Amiji M.M. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int. J. Pharm. 2005, 293(1-2):261-270.
49. Singh R.P., Sharad S., Kapur S. Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. J. Indian Acad. Clin. Med. 2004, 5(3):218-225.
50. Soares S., Mateus N., Freitas V.d. Interaction of different polyphenols with BSA and human salivary a-amylase (HSA) by fluorescence quenching. J. Agric. Food Chem. 2007, 55:6726.
51. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001, 70(1-2):1-20.
52. G. Thews, E. Mutschler, P. Vaupel, Anatomie, Physiologie, Pathophysiologie des Menschen, Publishers Wissenschaftliche Verlagsges, Stuttgart, 2007.
53. Vinogradov S., Batrakova E., Kabanov A. Poly(ethylene glycol)-polyethyleneimine NanoGel™ particles: novel drug delivery systems for antisense oligonucleotides. Colloids Surf. B 1999, 16:291-304.
54. Wu P., He X., Wang K., Tan W., He C., Zheng M. A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. J. Biomed. Nanotechnol. 2009, 5(5):557-564.
55. Wu T.H., Yen F.L., Lin L.T., Tsai T.R., Lin C.C., Cham T.M. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int. J. Pharm. 2008, 346(1-2):160-168.
56. Xiao J.B., Chen X.Q., Jiang X.Y., Hilczer M., Tachiya M. Probing the interaction of Trans-resveratrol with Bovine Serum Albumin: a fluorescence quenching study with Tachiya model. J. Fluoresc. 2008, 18:671-678.
57. Xiao J.B., Shi J., Cao H., Wu S.D., Ren F.L., Xu M. Analysis of binding interaction between puerarin and bovine serum albumin by multispectroscopic method. J. Pharm. Biomed. 2007, 45:609-615.
58. Xing J., Zhang D., Tan T. Studies on the oridonin-loaded poly(d,l-lactic acid) nanoparticles in vitro and in vivo. Int. J. Biol. Macromol. 2007, 40(2):153-158.
59. Yuan Z.P., Chen L.J., Fan L.Y., Tang M.H., Yang G.L., Yang H.S., Du X.B., Wang G.Q., Yao W.X., Zhao Q.M., Ye B., Wang R., Diao P., Zhang W., Wu H.B., Zhao X., Wei Y.Q. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res. 2006, 12(10):3193-3199.
60. Zambaux M.F., Bonneaux F., Gref R., Dellacherie E., Vigneron C. Preparation and characterization of protein C-loaded PLA nanoparticles. J. Control. Release 1999, 60(2-3):179-188.
61. Zhang Y.-Z., Zhou B., Liu Y.-X., Zhou C.-X., Ding X.-L., Liu Y. Fluorescence study on the interaction of Bovine Serum Albumin with p-aminobenzene. J. Fluoresc. 2008, 18:109.
62. Zheng X., Kan B., Gou M., Fu S., Zhang J., Men K., Chen L., Luo F., Zhao Y., Zhao X., Wei Y., Qian Z. Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro. Int. J. Pharm. 2010, 386(1-2):262-267.